Motofen Tablet
Product Images NDC 54766-200

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Motofen (NDC 54766-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca20010001 Motofen

Motofen® is a medication available as 1mg/0.025mg per tablet with NDC 54766-200-10. The recommended usual adult dosage is two tablets for the first time, then one table after each loose stool or one tablet every 310 4 hours as needed, with a maximum of 8 tablets in 24 hours. The medication contains difenoxin and atropine sulfate tablets and atropine sulfate. The product literature should be referred to for complete prescribing information. This is a bulk container not intended for household use, and it should be stored at 20°-25°C (68°77°F).*

FDA Label Image

100 Count Bottle Label (Picture1)

FDA Label Image

Difenoxin Hydrochloride (Motofen 01)

It seems like a chemical compound called Difenoxin Hydrochloride. No further information is available.*

FDA Label Image

Atropine Sulfate (Motofen 02)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.